Back to Özlem Türeci
    Özlem Türeci

    Özlem Türeci

    Awards & Honours

    7

    Awards Won

    4

    Honours

    2

    Rankings

    2

    Covers

    1

    Records

    Özlem Türeci's list of accolades reflects not just personal achievement but a collective scientific triumph. Her role in developing the first mRNA-based COVID-19 vaccine earned her a place on TIME's 100 Most Influential People list in 2021, alongside her husband. The same year, she received Germany's Federal Cross of Merit, one of the country's highest civilian honours. In 2022, she shared the Princess of Asturias Award for Technical and Scientific Research and the Paul Ehrlich and Ludwig Darmstaedter Prize, both recognizing the vaccine's impact. Her work also earned a Canada Gairdner International Award, one of the most prestigious prizes in medical science. In 2026, the University of Barcelona awarded her an honorary doctorate, describing her as someone capable of transforming a research laboratory into a space of hope.

    Özlem Türeci receiving an award

    Awards

    Honours & Distinctions

    Honorary Doctorate

    University of Barcelona·2026

    Awarded honoris causa for her contributions to science and medicine.

    German Future Prize

    Federal President of Germany·2023

    Awarded for the development of the COVID-19 vaccine.

    TIME 100 Most Influential People

    TIME·2021

    Listed among the world's most influential people.

    German Federal Cross of Merit

    Federal Republic of Germany·2021

    Awarded for her contributions to the COVID-19 vaccine effort.

    Rankings & Lists

    #1

    TIME 100 Most Influential People

    TIME·2021
    #1

    Financial Times Person of the Year

    Financial Times·2021

    Magazine Covers

    TIME

    2021

    The Vaccine Makers

    Forbes

    2021

    The Power Couple Behind the COVID-19 Vaccine

    Records & Feats

    Co-developed the first mRNA-based vaccine approved for human use

    Historic First·2020

    The COVID-19 vaccine BNT162b2, developed by BioNTech and Pfizer, was the first mRNA vaccine to receive regulatory approval.